Medication-assisted weight loss has boomed in recent yrs. How does weight loss affect disease activity & PROs in RMDs? ≥5% weight loss, after taking a med, led to better disease activity & QoL Data may inform RCTs to explore effect of these meds in RMDs Ab0845 #ACR24 @RheumNow

LTE of deucravacitinib trials in psoriasis. Remarkable & frankly surprising (to me) persistence of benefit Very encouraging for patients who start TYKs, looks like those who respond may have prolonged benefit #ACR24 @RheumNow Abstr#0290 #ACRBest https://t.co/kao4vqpPTQ

• https://x.com/EBRheum/status/1857888161440883147/photo/1
• https://x.com/EBRheum/status/1857888161440883147/photo/1
• https://x.com/EBRheum/status/1857888161440883147/photo/1

Don’t miss the “window of opportunity” for aggressive treatment in early RA! with active RA, risk of ILD 6x and RA-related lung disease 4x higher #ACR24 @RheumNow ABST#0802 https://t.co/yxlfInte6A

• https://x.com/JihaRheum/status/1857878808591794279/photo/1

Cannabis in Pain: CBD can help with nociceptive pain THC better for neuropathic, centralized pain Perhaps a role in helping decrease other medications like opiates Clauw 16S18 #ACR24 @RheumNow https://t.co/kaQXrD4GAn

• https://x.com/ericdeinmd/status/1857815945600778593/photo/1
• https://x.com/ericdeinmd/status/1857815945600778593/photo/1

How often should #scleroderma #ILD pts have #PFTs? 🤷‍♂️ Data from SENCIS RCT of SSc-ILD 25% worsened FVC by 6/12 Are we UNDER a ordering PFTs in an ILD #SSc population 👇 Because if worsening we would consider a change in background #immunesuppression @RheumNow #ACR24 #678 https://t.co/a9ybO3FwDd

• https://x.com/Janetbirdope/status/1857849016001655085/photo/1

Harkins @DrTrishHarkins et al. 1 year outcomes of 65 PMR patients treated in FTC. 32.7% experienced relapse, 28% still on GCs, 21% on tocilizumab. @RheumNow #ACR24 Abstr#0739 https://t.co/uYBYhPqGQE https://t.co/n9x9BDTPKg

• One Year Outcomes in Those with Isolated PMR Recruited via a Fast Track PMR Cli…
• https://x.com/RichardPAConway/status/1857828980243706152/photo/1

Abstract #0805 Data from OTIS Registry shows Certolizumab pegol (Cimzia) exposure during pregnancy was not associated with increased risk of major birth defects, structural defects, or adverse pregnancy outcomes. #ACR24 @RheumNow

Does alcohol consumption affect radiographic progression in axSpA? Canadian cohort study over 6 years found greater radiographic progression among alcohol consumers. Still a lot of confounding factors to fully establish an association. Abst#0822 #ACR24 @RheumNow https://t.co/GG0rXq3kjC

• https://x.com/AdelaCastro222/status/1857870372516839730/photo/1

Results from MANDARA- #EGPA pts treated with benralizumab or mepolizumab Eosinophil-targeting biologics rapidly control airway- & non-airway-related manifestations Few pts had worsening of disease that progressed to organ damage over 52W Ab0828 #ACR24 @RheumNow https://t.co/hIn9iyNVWQ

• https://x.com/DrMiniDey/status/1857869245658620106/photo/1

#Disparites posters #ACR24 - Analyzed 954 SLE patients - Black and Asian patients had higher severe damage events - Neighborhood disadvantage (ADI) linked to increased severe damage - Older age and comorbidities increased damage risk abst#0362 @rhuemnow